Divarasib plus cetuximab in KRAS G12C-positive colorectal cancer: a phase 1b trial
Jayesh Desai(Peter MacCallum Cancer Centre), Alejandro Falcón(Princess Margaret Cancer Centre), Manish R. Patel(Sarah Cannon), Víctor Moreno, Mark T. Lin(Princess Margaret Cancer Centre), Julie Chang(Stanford University), Thomas B. Karasic(Hospital of the University of Pennsylvania), Erminia Massarelli(The University of Texas MD Anderson Cancer Center), Guzmán Alonso(Vall d'Hebron Hospital Universitari), Jennifer L. Schutzman(Cancer Research Institute), Rasha Cosman(UNSW Sydney), Alessio Amatu(Azienda Socio Sanitaria Territoriale Grande Ospedale Metropolitano Niguarda), Neekesh V. Dharia(Broad Institute), Jia Luo(Dana-Farber Cancer Institute), Susanna V. Ulahannan(Oklahoma State University Oklahoma City), Adrian G. Sacher(Princess Margaret Cancer Centre), Kathryn C. Arbour(Memorial Sloan Kettering Cancer Center), Laura Medina(Instituto de Investigación Biomédica de Málaga), Wilson H. Miller(Jewish General Hospital), Luis Paz‐Ares(Hospital Universitario 12 De Octubre), Hans Prenen(Antwerp University Hospital), Tomi Jun(Sema4 (United States)), Zhen Shi, Se Hyun Kim(Seoul National University), Patricia LoRusso(Yale Cancer Center), Tormod Kyrre Guren(Oslo University Hospital), Stephanie Royer‐Joo(Princess Margaret Cancer Centre), Einat Shacham‐Shmueli(Sheba Medical Center), Eelke Gort(University Medical Center Utrecht), Chiara Cremolini(University of Pisa), Alessandro Passardi(Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori), Sai‐Hong Ignatius Ou(University of California, Irvine Medical Center), Andrés Cervantes(INCLIVA Health Research Institute), Sandhya Mandlekar(University of Illinois Chicago), Armando Santoro(IRCCS Humanitas Research Hospital), Tae Won Kim(Asan Medical Center), Rafał Stec(Medical University of Warsaw), Yoonha Choi(Ewha Womans University)
Cited by 128
Related Papers
Anaplastic Lymphoma Kinase Inhibition in Non–Small-Cell Lung Cancer
|New England Journal of Medicine|2010|4.5k
Leucovorin and Fluorouracil With or Without Oxaliplatin as First-Line Treatment in Advanced Colorectal Cancer
|Journal of Clinical Oncology|2000|3.8k
Pembrolizumab plus Chemotherapy for Squamous Non–Small-Cell Lung Cancer
|New England Journal of Medicine|2018|3.7k
Lung cancer: current therapies and new targeted treatments
|The Lancet|2016|3.3k